echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Confirmed the effectiveness of Treg cell transplantation in the treatment of fragile bone disease

    Confirmed the effectiveness of Treg cell transplantation in the treatment of fragile bone disease

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Mehrotra hopes to find the root cause of brittle bone disease, not just a palliative.



    The building blocks of the structure are made up of load-bearing elements that are rarely altered even when refurbished or repaired


    Bones are dynamic: they are constantly breaking down and rebuilding to become the strongest of their own


    Mutations in this bone regeneration process can cause bones to become fragile, and if this mutation is related to the amount of collagen produced in bones, connective tissue, skin, and cartilage, it can lead to fragile bone disease


    Fragile bone disease, also known as osteogenesis imperfecta, currently affects 20,000 to 50,000 people in the United States, but it is also the most common inherited bone disease


    Her goal is to find a safer way to treat this devastating disease


    Mehrotra says healthy bones are constantly experiencing and reshaping their micro-fractures


    There is a drug called bisphosphate that is currently being used to treat brittle bone disease


    In a recent paper, iScience, the research team used regulatory T cells (Treg cells) as a previously unmet treatment for fragile bone disease


    They found that the internal environment of mice with the disease was overinflamed


    With Treg transplants, the researchers demonstrated that increasing the number of Tregs does promote bone remodeling, which makes bones stronger


    Mehrotra and her team tested Treg cell transplantation with T cells from the affected mice themselves (autologous transplantation) and T cells from donor mice (allogeneic transplantation) and compared the results


    In two transplants, Mehrotra found an increase in the number of osteoblasts and a decrease in the number of osteoclasts


    But the part that excites her the most is that while both allogeneic and autologous transplants are effective, autologous transplants yield better


    After studying hematopoietic stem cells and brittle bone disease in previous studies, Mehrotra came up with the idea


    Next, she wanted to see why a genetic disease with a collagen mutation seemed to have nothing to do with immunity, but it had immunodeficiency
    .
    Then she wanted to see how increasing Treg had a positive effect on the
    bones.
    "For me, that's another puzzle," she said
    .
    Answering these two questions will help bring Treg cell transplants closer to the clinic for people with brittle bone disease
    .

    Quantitative increase in T regulatory cells enhances bone remodeling in osteogenesis imperfecta

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.